US FDA approves Tretten to treat rare genetic clotting disorder
Tretten is a recombinant analogue of the human Factor XIII A-subunit that is produced in yeast cells and then further purified
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
FDA and European Medicines Agency announce generic-drug application inspections initiative
The initiative creates a process to conduct joint facility inspections for generic-drug applications submitted to both agencies
CHMP recommends EU approval of Piramal Imaging’s NeuraCeq
NeuraCeq is a radio pharmaceutical indicated for Positron Emission Tomography (PET) imaging of neuritic beta-amyloid plaque…
Scientific sessions raise and discuss pertinent issues, job fair a hit
The second day of the 65th IPC saw increased participation by students in the pharma job fair as well as delegates in the…
65th IPC Delhi takes off with a grand start
In line with its theme of “Empowering the Pharmacist”, the event is set to see hot debates on pharma regulation, education and…
Daiichi to give technical assistance to Ranbaxy to meet US FDA norms
Is keen on upgrading good manufacturing practices at the Indian company’s domestic plants
Chugai Pharma Manufacturing adopts Lonza’s Quality Control Microbiology Automation platform
Agreement will allow Chugai Pharma Manufacturing to more efficiently process large amounts of QC sampling data with automated…
USAID extends USP’s Promoting the Quality of Medicines (PQM) programme
Will enable the programme to receive up to an additional $75 million in funds for technical assistance to strengthen country…